soul trial oral semaglutide cardiovascular outcomes 2024 2025 results SOUL: Cuts CV Events in Diabetic Patients soul trial oral semaglutide cardiovascular

Post-marketing pharmacovigilance data similarly have not established a causal link between semaglutide use and MTC in humans, though ongoing monitoring continues

There is a significant opportunity for the natural channel to be at the forefront of GLP-1 nutrition, just like it has been at the forefront of so many other consumer health trends, like gut health, Washington says

However, its side effects and cost are important considerations for potential users

Eating smaller meals, avoiding fatty or spicy foods, and staying hydrated can help

After a minute or two, it is degraded by an enzyme known as DPP-4 (dipeptidyl peptidase-4)